Cocrystal Pharma, Inc. (COCP)

1.015 0.00 (0.00%) USD  |  NASDAQ  |  Jun 09, 16:00
1.015 0.00 (0.00%) After-Hours: 16:41
More

Cocrystal Pharma SG&A Expense (Quarterly) : 1.21M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for COCP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
CNBX Pharmaceuticals, Inc. 0.073M
GB Sciences, Inc. --
Arvinas, Inc. 19.10M
Fulcrum Therapeutics, Inc. 8.102M
Definium Therapeutics, Inc. 17.74M